Image 1.jpg
mPhase Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
May 12, 2021 16:01 ET | mPhase Technologies, Inc.
Gaithersburg, MD, May 12, 2021 (GLOBE NEWSWIRE) -- mPhase Technologies, Inc. (OTC: XDSL) (“mPhase” or the “Company”), a technology company specializing in EV charging, artificial intelligence,...
17_NV5_full-color_RGB_VTL_O.jpg
NV5 Announces Strong First Quarter Results; Delivers Record Cash Flows and Issues Full-Year 2021 Guidance Exceeding Analyst Consensus
May 12, 2021 16:01 ET | NV5 Global, Inc.
HOLLYWOOD, Fla., May 12, 2021 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (Nasdaq: NVEE) ("NV5" or the "Company"), a leading provider of compliance, technology, and engineering consulting solutions, today...
PlayboyLogo.png
PLBY Group Reports First Quarter 2021 Financial Results
May 12, 2021 16:01 ET | PLBY Group, Inc.
LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most...
Main Orange.png
Eargo Reports First Quarter 2021 Financial Results
May 12, 2021 16:01 ET | Eargo
Recent Highlights: Net revenues of $22.0 million, up 74.0% year-over-yearGross systems shipped of 11,704, up 66.5% year-over-yearReturn accrual rate of 23.2%, a 4.4 percentage point improvement...
Flexion Logo.jpg
Flexion Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Updates
May 12, 2021 16:01 ET | Flexion Therapeutics, Inc.
Flexion reported ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) net sales of $24.6 millionDavid Arkowitz, CFO, stepping down effective May 31,2021, and will be succeeded by...
CELYAD.jpg
Celyad Oncology to Present Data from Phase 1 IMMUNICY-1 Trial of Non-Gene Edited Allogeneic CAR T Candidate CYAD-211 in Relapsed/Refractory Multiple Myeloma at the European Hematology Association Virtual Congress
May 12, 2021 16:01 ET | Celyad Oncology SA
No Grade ≥ 3 treatment-related adverse events nor evidence of Graft-versus-Host disease reported from the completed first dose-level (DL1) cohort of Phase 1 dose-escalation IMMUNICY-1 trial evaluating...
Micron logo_blue_RGB.jpg
Micron Technology Announces Upcoming Investor Events
May 12, 2021 16:01 ET | Micron Technology, Inc.
BOISE, Idaho, May 12, 2021 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), today announced its participation in the following investor events: Chief Financial Officer David Zinsner will...
Keros.jpg
Keros Therapeutics to Present at the Virtual 26th Annual Congress of the European Hematology Association
May 12, 2021 16:01 ET | Keros Therapeutics, Inc.
LEXINGTON, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and...
logo.png
Kratos to Present at the 16th Annual Needham Virtual Technology & Media Conference
May 12, 2021 16:00 ET | Kratos Defense & Security Solutions, Inc.
SAN DIEGO, May 12, 2021 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a leading National Security Solutions provider, today announced that its President &...
birchcliff-logo.jpg
Birchcliff Energy Ltd. Announces Q1 2021 Financial and Operational Results and Increases Its 2021 Production, Adjusted Funds Flow and Free Funds Flow Guidance
May 12, 2021 16:00 ET | Birchcliff Energy Ltd.
CALGARY, Alberta, May 12, 2021 (GLOBE NEWSWIRE) -- Birchcliff Energy Ltd. (“Birchcliff” or the “Corporation”) (TSX: BIR) is proud to announce its strong financial and operational results for the...